Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | PRCP | P42785 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 4/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | SCN4A | P35499 | 1/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.34 |
| ▸ | TLR2 | O60603 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6026726 | 0.98 | NOS2 (0.36) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL28695544 | 0.98 | NOS2 (0.36) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL1740647 | 0.88 | NOS2 (0.36) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL27646576 | 0.86 | NOS2 (0.39) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL20839948 | 0.86 | NOS2 (0.35) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL7378973 | 0.86 | NOS2 (0.35) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL15210886 | 0.86 | NOS2 (0.39) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL499450 | 0.86 | NOS2 (0.39) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL2543576 | 0.85 | NOS2 (0.38) | NOS2NOS3NOS1PRCPDPP4 | |
| SCHEMBL11560633 | 0.85 | CYP3A4 (0.36) | NOS2NOS3NOS1PRCPDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219928-A1 | PREPARATION METHOD FOR AROMATIC ETHER COMPOUND | ASIERIS PHARMACEUTICALS (SHANGHAI) CO., LTD. (CN) | 2023-07-13 | — | — | US | disclosed |
| EP-4177243-A1 | PREPARATION METHOD FOR AROMATIC ETHER COMPOUND | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2023-05-10 | — | — | EP | disclosed |
| US-5202443-A | PROCESS FOR PREPARING 1-(2S)-3-MERCAPTO-METHYL-1-OXOPROPYL)-L-PROLINE | EGIS GYOGYSZERGYAR (HU) | 1993-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219928-A1 | PREPARATION METHOD FOR AROMATIC ETHER COMPOUND | F7, F5, CYP2F1 | NOS2 2995/4885NOS3 3105/4885NOS1 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.